Published On: Sat, Sep 17th, 2016

NantHealth Inc (NH) Cut to Sell at Zacks Investment Research

NantHealth Inc (NYSE:NH) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Wednesday.
According to Zacks, “Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets of molecular, clinical, operational and financial data points derived from novel and traditional sources. Nant Health, LLC is based in CULVER CITY, United States. “
Several other equities analysts have also recently issued reports on NH. FBR & Co initiated coverage on NantHealth in a report on Monday, June 27th. They issued an “outperform” rating and a $18.00 price target on the stock. Cowen and Company initiated coverage on NantHealth in a report on Monday, June 27th. They issued an “outperform” rating and a $19.00 price target on the stock. First Analysis initiated coverage on NantHealth in a report on Monday, June 27th. They issued an “overweight” rating and a $18.00 price target on the stock. Canaccord Genuity initiated coverage on NantHealth in a report on Monday, June 27th. They issued a “buy” rating and a $17.00 price target on the stock. Finally, Jefferies Group initiated coverage on NantHealth in a report on Monday, June 27th. They issued a “buy” rating on the stock. One equities research analyst has rated the stock with a sell rating and five have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $18.00.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/17/nanthealth-inc-nh-cut-to-sell-at-zacks-investment-research.html

NantHealth (NYSE:NH) opened at 14.50 on Wednesday. The stock has a 50 day moving average price of $12.02 and a 200-day moving average price of $12.54. NantHealth has a one year low of $9.79 and a one year high of $16.63. The firm’s market cap is $1.76 billion.
NantHealth (NYSE:NH) last announced its earnings results on Tuesday, August 9th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.41) by $0.26. The business had revenue of $31.50 million for the quarter, compared to the consensus estimate of $23.55 million. The business’s revenue was up 166.9% compared to the same quarter last year. Analysts predict that NantHealth will post ($0.63) EPS for the current fiscal year.
A number of institutional investors have recently modified their holdings of the company. Wildcat Capital Management LLC bought a new position in shares of NantHealth during the second quarter worth about $3,008,000. Jefferies Group LLC bought a new position in shares of NantHealth during the second quarter worth about $6,943,000. Blackstone Group L.P. bought a new position in shares of NantHealth during the second quarter worth about $7,463,000. Finally, FMR LLC bought a new position in shares of NantHealth during the second quarter worth about $11,250,000.
NantHealth Company Profile
NantHealth, Inc, formerly Nant Health, LLC, is an evidence-based, personalized healthcare company. The Company’s systems-based approach to personalized healthcare applies diagnostics tailored to specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with real-time biometric signal and phenotypic data to track patient outcomes and deliver medicine.

Get a free copy of the Zacks research report on NantHealth (NH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for NantHealth Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for NantHealth Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>